BRPI0413107A - vacinas seguras de mutantes virais - Google Patents

vacinas seguras de mutantes virais

Info

Publication number
BRPI0413107A
BRPI0413107A BRPI0413107-0A BRPI0413107A BRPI0413107A BR PI0413107 A BRPI0413107 A BR PI0413107A BR PI0413107 A BRPI0413107 A BR PI0413107A BR PI0413107 A BRPI0413107 A BR PI0413107A
Authority
BR
Brazil
Prior art keywords
viruses
vaccines
mutations
viral mutant
present
Prior art date
Application number
BRPI0413107-0A
Other languages
English (en)
Inventor
Siao-Kun Wan Welch
Jay Gregory Calvert
Michael K O'hara
Xuemei Cao
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34272474&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0413107(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BRPI0413107A publication Critical patent/BRPI0413107A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"VACINAS SEGURAS DE MUTANTES VIRAIS". A presente invenção refere-se a vacinas seguras e aos métodos de preparação de tais vacinas. As vacinas da presente invenção contêm pelo menos dois vírus mutantes vivos da mesma família ou as moléculas dos ácidos nucléicos que codificam tais vírus, nas quais cada um dos dois vírus ou os ácidos nucléicos que os codificam contêm uma mutação que confere um fenótipo desejável, e as mutações nos vírus residem no mesmo local genómico, de modo que os vírus mutantes não possam recombinar-se entre si, a fim de eliminar as mutações.
BRPI0413107-0A 2003-07-29 2004-07-26 vacinas seguras de mutantes virais BRPI0413107A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49083403P 2003-07-29 2003-07-29
PCT/US2004/024011 WO2005021034A2 (en) 2003-07-29 2004-07-26 Safe mutant viral vaccines

Publications (1)

Publication Number Publication Date
BRPI0413107A true BRPI0413107A (pt) 2006-10-03

Family

ID=34272474

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0413107-0A BRPI0413107A (pt) 2003-07-29 2004-07-26 vacinas seguras de mutantes virais

Country Status (27)

Country Link
US (2) US7361357B2 (pt)
EP (1) EP1651263B9 (pt)
JP (1) JP4662931B2 (pt)
KR (1) KR100810820B1 (pt)
CN (1) CN1976717A (pt)
AT (1) ATE489107T1 (pt)
AU (1) AU2004268514B2 (pt)
BR (1) BRPI0413107A (pt)
CA (1) CA2533877C (pt)
CY (1) CY1110995T1 (pt)
DE (1) DE602004030253D1 (pt)
DK (1) DK1651263T3 (pt)
EA (1) EA009391B1 (pt)
ES (1) ES2355276T3 (pt)
IL (1) IL173338A0 (pt)
IS (1) IS8254A (pt)
NO (1) NO20060931L (pt)
NZ (1) NZ545612A (pt)
PL (1) PL1651263T3 (pt)
PT (1) PT1651263E (pt)
RS (1) RS51456B (pt)
SI (1) SI1651263T1 (pt)
TN (1) TNSN06031A1 (pt)
TW (1) TWI342783B (pt)
UA (1) UA85845C2 (pt)
WO (1) WO2005021034A2 (pt)
ZA (1) ZA200600585B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) * 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US7361357B2 (en) * 2003-07-29 2008-04-22 Pfizer Inc. Safe mutant viral vaccines
US7572455B2 (en) * 2004-05-19 2009-08-11 Boehringer Ingelheim Vetmedica Gmbh Vaccine comprising an attenuated pestivirus
US8834891B2 (en) * 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
UY29915A1 (es) * 2005-11-15 2007-06-29 Boehringer Ingelheim Vetmed Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina
US7666585B2 (en) * 2007-06-15 2010-02-23 Protatek International, Inc. Construction of chimera PRRSV, compositions and vaccine preparations
US8114852B2 (en) * 2008-01-15 2012-02-14 The United States Of America As Represented By The Secretary Of Agriculture N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
ES2681685T3 (es) * 2008-12-03 2018-09-14 Zoetis Services Llc Virus de la diarrea vírica bovina con una proteína Erns modificada
US8846054B2 (en) * 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
MX351380B (es) * 2010-12-27 2017-10-12 Lilly Co Eli Composiciones y metodos de vacuna de tipo ib de virus de diarrea viral de bovino.
RU2457859C1 (ru) * 2011-01-12 2012-08-10 Федеральное государственное бюджетное учреждение "Федеральный центр охраны здоровья животных" (ФГБУ "ВНИИЗЖ") Вакцина против вирусной диареи крупного рогатого скота
CN105985413A (zh) * 2015-02-28 2016-10-05 中国科学院上海巴斯德研究所 新的甲型流感病毒哺乳动物细胞适应株及其制备和应用
KR102580161B1 (ko) 2017-08-02 2023-09-20 순천향대학교 산학협력단 백신의 중추신경계 안전성 검사를 위한 양성대조군의 제조방법 및 이를 이용한 검사 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US6001613A (en) * 1996-05-24 1999-12-14 Board Of Regents Of University Of Nebraska Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
JP2001515468A (ja) 1997-02-14 2001-09-18 メルク エンド カンパニー インコーポレーテッド ポリヌクレオチドワクチン製剤
ME00810B (me) * 2002-08-26 2012-03-20 Zoetis Services Llc Vakcina za infekcije respiratornog i reproduktivnog sistema kod stoke
US7563449B2 (en) * 2003-04-21 2009-07-21 Pfizer Inc, Methods for reducing cattle reproductive diseases
US7361357B2 (en) 2003-07-29 2008-04-22 Pfizer Inc. Safe mutant viral vaccines

Also Published As

Publication number Publication date
PT1651263E (pt) 2011-01-25
JP4662931B2 (ja) 2011-03-30
KR100810820B1 (ko) 2008-03-06
PL1651263T3 (pl) 2011-04-29
IL173338A0 (en) 2006-06-11
ATE489107T1 (de) 2010-12-15
NZ545612A (en) 2009-11-27
US7361357B2 (en) 2008-04-22
CA2533877A1 (en) 2005-03-10
ES2355276T3 (es) 2011-03-24
ZA200600585B (en) 2007-03-28
NO20060931L (no) 2006-04-27
WO2005021034A3 (en) 2005-12-29
RS20060045A (en) 2008-06-05
US20050053621A1 (en) 2005-03-10
SI1651263T1 (sl) 2011-02-28
TW200514568A (en) 2005-05-01
ES2355276T9 (es) 2011-03-25
EP1651263A2 (en) 2006-05-03
EA009391B1 (ru) 2007-12-28
DK1651263T3 (da) 2011-01-31
UA85845C2 (uk) 2009-03-10
CN1976717A (zh) 2007-06-06
DE602004030253D1 (de) 2011-01-05
EA200600121A1 (ru) 2006-10-27
EP1651263B1 (en) 2010-11-24
WO2005021034A2 (en) 2005-03-10
US20080286302A1 (en) 2008-11-20
AU2004268514B2 (en) 2010-01-21
AU2004268514A1 (en) 2005-03-10
CA2533877C (en) 2011-09-06
KR20060092198A (ko) 2006-08-22
RS51456B (en) 2011-04-30
JP2007500702A (ja) 2007-01-18
US7754222B2 (en) 2010-07-13
EP1651263B9 (en) 2011-02-16
TNSN06031A1 (fr) 2007-10-03
TWI342783B (en) 2011-06-01
CY1110995T1 (el) 2015-06-11
IS8254A (is) 2006-01-23

Similar Documents

Publication Publication Date Title
NO20060931L (no) Trygge mutante virusvaksiner
MXPA03011412A (es) Alteracion de caracteristicas de aceite en plantas.
EP1554301A4 (en) TETRAVALENT DENGUE VACCINE WITH A BLACK 30 NUCLEOTIDE DELETION IN 3'-UTR OF DENGUE TYPES 1,2,3 AND 4, OR ANTIGEN CHIMERAL DENGUE VIRUSES 1,2,3 AND 4
UA97623C2 (ru) Растение, содержащее мутацию в домене с ahas белка, которая обеспечивает повышенную толерантность к имидазолиноновым гербицидам
SG142154A1 (en) Methods for genomic analysis
ATE507242T1 (de) Wirtszellenspezifische bindungsmoleküle, die dazu in der lage sind, viren zu neutralisieren, und anwendungen davon
NO20084488L (no) Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith
WO2006136448A3 (en) Attenuated sars and use as a vaccine
EA200701695A1 (ru) Рнк вирусы с ослабленной способностью к репликации в качестве вакцин
HUP0303431A2 (hu) PRRS vírus élő legyengített törzsei
HUP0302612A2 (hu) Salmonella vakcina
WO2004071430A3 (en) RNAi TARGETING OF VIRUSES
DK1066376T3 (da) Svækkede bakterier ved hjælp af en ikke-reverterende mutation i hver af AROC-, OMPF- og OMPC-generne, der er anvendelige i vacciner
GB2458057A (en) Francisella strain for live vaccine
WO2011060534A8 (en) Trim5alpha mutants and uses thereof
ATE441728T1 (de) Mit cmv-resistenz assoziierter molekularer marker und verwendung davon
ATE408013T1 (de) Infektiöses cdna klon des gb-virus b und dessen verwendungen
Bosch et al. Coding biases and viral fitness
DE50312368D1 (de) Rekombinante mva-stamme als potentielle impfstoffe gegen p. falciparum -malaria
WO2004000998A3 (en) Compositions and methods for viral resistance genes
WO2005090584A3 (de) Impfstoff gegen influenza basierend auf geflügelpestviren
Wimmer et al. The future of synthetic virology
AU2001258579A1 (en) Virulence genes, proteins, and their use
WO2002081712A3 (en) Artificial chromosomes comprising ehv sequences
WO2008091659A3 (en) Methods and compositions for predicting and treating drug resistant strains of influenza virus

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: PAH USA 15 LLC (US)

B25D Requested change of name of applicant approved

Owner name: ZOETIS P LLC (US)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 24, 8 E 13, 8 E 11, 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.